Humasis

휴마시스 · 205470

Health Care Pharmaceuticals · KOSDAQ

Small-cap

Market cap US$57.8M (₩79.7B)

Overview

Company summary coming soon.

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$21.8M

▲ +18.5% YoY

Operating profit · FY2025

−US$7.6M

Loss narrowed

Net income · FY2025

−US$15.7M

Loss narrowed

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$10M(₩13.8B)	US$18.4M(₩25.4B)	US$21.8M(₩30.1B)
Operating profit	−US$37.9M(−₩52.4B)	−US$7.7M(−₩10.6B)	−US$7.6M(−₩10.6B)
Net income	−US$40.2M(−₩55.4B)	−US$25.8M(−₩35.6B)	−US$15.7M(−₩21.7B)

Revenue

Operating profit

Net income

ROE

-9.2%

Debt/Eq

38.9%

Op. margin

-35.0%

Net margin

-72.2%

Rev. YoY

▲ +18.5%

Interactive price history isn't here yet. Would you use it?